Panbela Therapeutics, Inc.【PBLA】Balance sheet

Market cap

$63.36K

P/E ratio

	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12
Cash and cash equivalents	110,938	58,822	163,772	925,000	438,000	152,000	1	2	9	12	1	3
Total cash & short-term investments	110,938	58,822	163,772	925,000	438,000	152,000	1	2	9	12	1	3
Accounts receivable, net	75,482	14,800	18,080	-	-	-	-	-	-	-	-	-
Total current assets	336,809	432,843	391,077	2	1	1	2	3	10	12	2	3
Property, plant and equipment, net	15,877	19,198	13,006	-	-	-	-	-	-	-	-	-
Total non-current assets	274,097	99,418	16,039	0	-	-	0	0	0	1	3	9
Total assets	610,906	532,261	407,116	2	1	1	2	3	10	13	5	12
Accounts payable	28,142	3,995	340	1	1	1	1	1	1	1	3	10
Long-term debt, current	-	-	-	-	0	0	0	-	-	-	-	-
Total current liabilities	643,504	663,695	615,662	1	6	4	2	2	1	3	8	12
Long-term debt, non-current	-	-	-	0	-	0	-	-	-	-	5	4
Total non-current liabilities	8,249	6,458	2,413	3	-	0	-	-	-	-	5	4
Total liabilities	651,753	670,153	618,075	-	-	-	-	2	1	3	13	17
Common stock and paid-in capital	13	14	7	11	14	26	35	42	55	66	82	120
Retained earnings	-13,669,971	-13,881,992	-13,989,036	-14	-19	-29	-35	-41	-46	-56	-91	-125
Stockholders' equity	-40,847	-137,892	-210,959	-3	-5	-4	0	1	8	10	-8	-5
Total debt	-	-	-	0	0	0	0	-	-	-	5	4
Net debt	-	-	-	-638,000	-144,000	0	-1	-	-	-	4	2
D/E ratio (%)	-	-	-	-10.7	-6.3	-8.1	106.7	-	-	-	-64.9	-89.2